Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.12.17	Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer (RTTNews)
19.12.17	Pfizer Board Approves New $10 Bln Share Buy-back; Hikes Dividend (RTTNews)
18.12.17	Pfizer Declares First-Quarter 2018 Dividend (Businesswire)
15.12.17	Pfizer Inc. Announces Expiration and Results of its Private Exchange Offer for its 6.500 per cent. Notes due 2038 and Related Tender Offer (Businesswire)
15.12.17	Pfizer Says FDA Okays XELJANZ And XELJANZ XR To Treat Active Psoriatic Arthritis (RTTNews)
15.12.17	Pfizer Announces FDA Approval of XELJANZ® (tofacitinib) and XELJANZ® XR for the Treatment of Active Psoriatic Arthritis (Businesswire)
14.12.17	Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for its 6.500 per cent. Notes due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors (Businesswire)
14.12.17	Pfizer Initiates Phase 3 Program For PF-04965842 - Quick Facts (RTTNews)
14.12.17	Pfizer Initiates Phase 3 Program for PF-04965842, a JAK1 Inhibitor in Development for Moderate-to-Severe Atopic Dermatitis (Businesswire)
14.12.17	Pfizer Biosimilar Medicine IXIFI Gets FDA Approval For All Eligible Indications (RTTNews)
14.12.17	FDA Approves New Pfizer Biosimilar (Businesswire)
13.12.17	Phase 3 TRUMENBA® (Meningococcal Group B Vaccine) Data Published in New England Journal of Medicine Demonstrate the Vaccine’s Immunogenicity (Businesswire)
13.12.17	ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use (RTTNews)
12.12.17	U.S. Food And Drug Administration Extends Action Date For XELJANZ® (Tofacitinib) Supplemental New Drug Application In Ulcerative Colitis By Three Months (Businesswire)
12.12.17	Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib (RTTNews)
11.12.17	Spark, Pfizer Record Sustained Factor IX Activity Levels In SPK-9001 Trial (RTTNews)
08.12.17	Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial (RTTNews)
08.12.17	Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer (Businesswire)
06.12.17	Updated Data from Phase 3 Trial of IBRANCE® (palbociclib) Plus Letrozole in ER+, HER2- Metastatic Breast Cancer Confirm Improvement in Progression-Free Survival (Businesswire)
05.12.17	Bristol-Myers Squibb and Pfizer Alliance Urge People to ‘Tune in to AFib, Take Note of Stroke Risk’ (Businesswire)
04.12.17	BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS (RTTNews)
01.12.17	Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific (RTTNews)
01.12.17	Pfizer Enters into Agreement to Develop and Commercialize CRESEMBA® (isavuconazole) in China and Asia Pacific Region (Businesswire)
29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
29.11.17	EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark (RTTNews)
28.11.17	Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer (PR Newswire)
28.11.17	Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint (RTTNews)
22.11.17	ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV (RTTNews)
22.11.17	Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection (PR Newswire)
17.11.17	FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche (RTTNews)
17.11.17	Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning (RTTNews)
16.11.17	Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma (Businesswire)
13.11.17	Minister Chagger celebrates Global Entrepreneurship Week 2017 (PR Newswire)
13.11.17	Pfizer Appoints Albert Bourla As COO (RTTNews)
13.11.17	Pfizer Names Albert Bourla Chief Operating Officer (Businesswire)
10.11.17	BMS-Pfizer Alliance to Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation (Businesswire)
31.10.17	Pfizer Lifts FY17 Adj. EPS View Above Market As Q2 Profit Tops Estimates (RTTNews)
31.10.17	Pfizer Inc. Q3 Earnings Rise 8% (RTTNews)
31.10.17	PFIZER REPORTS THIRD-QUARTER 2017 RESULTS (Businesswire)
30.10.17	One Year Maintenance and Switching Data in Patients with Crohn’s Disease Support the Use of INFLECTRA®* (infliximab CT-P13) in IBD1 (Businesswire)
19.10.17	Rio Tinto et CGI élargissent leur partenariat en technologie numérique (PR Newswire)
16.10.17	Pfizer: Trial Of ALK-Inhibitor Lorlatinib Shows Clinically Meaningful Activity (RTTNews)
13.10.17	ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS (RTTNews)
12.10.17	Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV (RTTNews)
10.10.17	Pfizer Reviews Strategic Alternatives For Consumer Healthcare Unit, Incl Sale (RTTNews)
09.10.17	New Drugs Approved In September (RTTNews)
27.09.17	Bavencio Approved For Merkel Cell Carcinoma In Japan (RTTNews)
21.09.17	Merck, Pfizer Report EU Marketing Authorization For BAVENCIO - Quick Facts (RTTNews)
21.09.17	European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma (PR Newswire)
21.09.17	FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

07:18		Roche-Aktie: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

07:18

Roche-Aktie: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester